Overall, significant differences of IL-17 have not been observed in SSc patients versus controls; however, IL-17A, IL-17B, IL-17E, and IL-17F were significantly elevated in SSc patients, and IL-17E and IL-F have been associated with DU [60–62]. This evidence concerns the gene FOXK2 and systemic sclerosis.